Average Co-Inventor Count = 5.92
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (47 from 3,684 patents)
2. Viiv Healthcare UK (no.5) Limited (6 from 42 patents)
3. Viiv Healthcare UK Limited (9 patents)
4. Bristol-myers Squibb Holdings Ireland (0 patent)
53 patents:
1. 11958834 - Inhibitors of human immunodeficiency virus replication
2. 11505543 - 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
3. 10954252 - Inhibitors of human immunodeficiency virus replication
4. 10617675 - Hepatitis C virus inhibitors
5. 10221129 - Inhibitors of human immunodeficiency virus replication
6. 10047056 - Hepatitis C virus inhibitors
7. 10035760 - Inhibitors of human immunodeficiency virus replication
8. 9855230 - Inhibitors of human immunodeficiency virus replication
9. 9775831 - Combinations comprising biphenyl derivatives for use in the treatment of HCV
10. 9776981 - Hepatitis C virus inhibitors
11. 9770439 - Hepatitis C virus inhibitors
12. 9758487 - Hepatitis C virus inhibitors
13. 9717712 - Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
14. 9561212 - Hepatitis C virus inhibitors
15. 9546160 - Hepatitis C virus inhibitors